LumiraDx to reduce headcount by ~40%

Andrii Yalanskyi
- Diagnostics testing solutions company LumiraDx (NASDAQ:LMDX) said on Thursday that it is set to reduce its headcount by ~40%.
- The move is a part of its strategic refocus and cost restructuring program, which aims to streamline strategic focus and operations, optimize cost structure and position the company for sustainable growth.
- The headcount reductions include full-time, part-time and contractor positions.
- Additionally, LumiraDx will continue to implement its operating cost reductions.
- The cost restructuring initiative is expected to result in annualized savings of ~$36M.
- LMDX shares were trading +1.82% pre-market.
- Source: Press Release